BDBM638725 US20230390272, Compound 1::US20240261273, Compound 1

SMILES CCCN1CCC(O)(CC1)c1cccc(c1)S(C)(=O)=O

InChI Key InChIKey=ZDXQESGEKBKRGR-UHFFFAOYSA-N

Data  6 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 638725   

TargetSigma non-opioid intracellular receptor 1(Human)
Prilenia Neurotherapeutics

US Patent
LigandPNGBDBM638725(US20230390272, Compound 1 | US20240261273, Compoun...)
Affinity DataKi:  370nMAssay Description:In-vitro binding assays performed at Eurofins Panlabs Taiwan, Ltd. Specific ligand binding was determined in the presence of an excess of unlabelled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2024
Entry Details
Go to US Patent

TargetSigma non-opioid intracellular receptor 1(Human)
Prilenia Neurotherapeutics

US Patent
LigandPNGBDBM638725(US20230390272, Compound 1 | US20240261273, Compoun...)
Affinity DataKi:  370nMAssay Description:In-vitro binding assays performed at Eurofins Panlabs Taiwan, Ltd. Specific ligand binding was determined in the presence of an excess of unlabelled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetSigma non-opioid intracellular receptor 1(Human)
Prilenia Neurotherapeutics

US Patent
LigandPNGBDBM638725(US20230390272, Compound 1 | US20240261273, Compoun...)
Affinity DataKi:  370nMAssay Description:In vitro binding assay performed at Eurofins Panlabs Taiwan, ltd. Specific ligand binding was determined in the presence of an excess of unlabelled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2024
Entry Details
Go to US Patent

TargetSigma intracellular receptor 2(Human)
Prilenia Neurotherapeutics

US Patent
LigandPNGBDBM638725(US20230390272, Compound 1 | US20240261273, Compoun...)
Affinity DataKi: >1.00E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2024
Entry Details
Go to US Patent

TargetSigma intracellular receptor 2(Human)
Prilenia Neurotherapeutics

US Patent
LigandPNGBDBM638725(US20230390272, Compound 1 | US20240261273, Compoun...)
Affinity DataKi: >1.00E+5nMAssay Description:In-vitro binding assays performed at Eurofins Panlabs Taiwan, Ltd. Specific ligand binding was determined in the presence of an excess of unlabelled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetSigma intracellular receptor 2(Human)
Prilenia Neurotherapeutics

US Patent
LigandPNGBDBM638725(US20230390272, Compound 1 | US20240261273, Compoun...)
Affinity DataKi: >1.00E+5nMAssay Description:In vitro binding assay performed at Eurofins Panlabs Taiwan, ltd. Specific ligand binding was determined in the presence of an excess of unlabelled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2024
Entry Details
Go to US Patent